Mark Levis, MD, PhD, is a professor of oncology, medicine and pharmacology at the Johns Hopkins University School of Medicine.
Dr Levis received his medical degree at the San Francisco School of Medicine, where he also earned his PhD in Biochemistry.
He co-directs the Hematologic Malignancies and Bone Marrow Transplantation Program and directs the Adult Leukemia Service at the Johns Hopkins Sidney Kimmel Cancer Center. In addition to his role within the Kimmel Cancer Center, he serves on the faculty for the Johns Hopkins Graduate Training Program in Cellular and Molecular Medicine.
Dr Levis is board certified in medical oncology, with his expertise in acute and chronic lymphoblastic leukemia, acute and chronic myeloid leukemia, hematology and medical oncology, and myelodysplastic syndromes. He is a clinical scholar of the Leukemia and Lymphoma Society, as well as a member of the American Society of Hematology, the American Society of Clinical Oncology and the European Hematology Association.
His laboratory research focuses on the development of molecularly-targeted therapies for leukemia. In addition to his work in both the clinic and the laboratory, Dr Levis has also conducted talks, mentorship and teaching lectures, and published extensively in the top journals in his field, including Leukemia; Blood; and the New England Journal of Medicine.
Dr Levis has earned numerous awards, such as the Daniel Nathans Research Award from Johns Hopkins University, the Osler Housestaff Teaching Award, the Director’s Teaching Award in Clinical Science, and the Advanced Clinical Research Award from the American Society of Clinical Oncology.